Successful Lenvatinib Re-challenge following Atezolizumab Plus Bevacizumab Combination Therapy Failure for Unresectable Hepatocellular Carcinoma

por Kosaka, Yumi, Kawaoka, Tomokazu, Kosaka, Masanari, Shirane, Yuki, Miura, Ryoichi, Murakami, Serami, Johira, Yusuke, Yano, Shigeki, Amioka, Kei, Naruto, Kensuke, Ando, Yuwa, Kodama, Kenichiro, Uchikawa, Shinsuke, Fujino, Hatsue, Ohno, Atsushi, Nakahara, Takashi, Murakami, Eisuke, Okamoto, Wataru, Yamauchi, Masami, Imamura, Michio, Aikata, Hiroshi
Publicado 2022

Benign Recurrent Intrahepatic Cholestasis Type 1 with Novel Nonsense Mutations in the ATP8B1 Gene

por Miura, Ryoichi, Kawaoka, Tomokazu, Imamura, Michio, Kosaka, Masanari, Johira, Yusuke, Shirane, Yuki, Murakami, Serami, Yano, Shigeki, Amioka, Kei, Naruto, Kensuke, Ando, Yuwa, Kosaka, Yumi, Kodama, Kenichiro, Uchikawa, Shinsuke, Fujino, Hatsue, Ono, Atsushi, Nakahara, Takashi, Murakami, Eisuke, Yamauchi, Masami, Hinoi, Takao, Aikata, Hiroshi
Publicado 2022

Risk Factors for Early Onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma

por Ando, Yuwa, Kawaoka, Tomokazu, Kosaka, Masanari, Shirane, Yuki, Johira, Yusuke, Miura, Ryoichi, Murakami, Serami, Yano, Shigeki, Amioka, Kei, Naruto, Kensuke, Kosaka, Yumi, Uchikawa, Shinsuke, Kodama, Kenichiro, Fujino, Hatsue, Nakahara, Takashi, Ono, Atushi, Murakami, Eisuke, Yamauchi, Masami, Okamoto, Wataru, Takahashi, Shoichi, Imamura, Michio, Aikata, Hiroshi
Publicado 2022

Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and...

por Kinami, Takahiro, Amioka, Kei, Kawaoka, Tomokazu, Uchikawa, Shinsuke, Yamasaki, Shintaro, Kosaka, Masanari, Johira, Yusuke, Yano, Shigeki, Naruto, Kensuke, Ando, Yuwa, Yamaoka, Kenji, Fujii, Yasutoshi, Fujino, Hatsue, Nakahara, Takashi, Ono, Atsushi, Murakami, Eisuke, Okamoto, Wataru, Yamauchi, Masami, Miki, Daiki, Tsuge, Masataka, Imamura, Michio, Aikata, Hiroshi, Oka, Shiro
Publicado 2023

Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice

por Ando, Yuwa, Kawaoka, Tomokazu, Kosaka, Masanari, Shirane, Yuki, Johira, Yusuke, Miura, Ryoichi, Murakami, Serami, Yano, Shigeki, Amioka, Kei, Naruto, Kensuke, Kosaka, Yumi, Uchikawa, Shinsuke, Kodama, Kenichiro, Fujino, Hatsue, Nakahara, Takashi, Ono, Atsushi, Murakami, Eisuke, Yamauchi, Masami, Okamoto, Wataru, Takahashi, Shoichi, Imamura, Michio, Chayama, Kazuaki, Aikata, Hiroshi
Publicado 2021

Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma

por Yano, Shigeki, Kawaoka, Tomokazu, Yamasaki, Shintaro, Johira, Yusuke, Kosaka, Masanari, Shirane, Yuki, Miura, Ryoichi, Amioka, Kei, Naruto, Kensuke, Yamaoka, Kenji, Fujii, Yasutoshi, Uchikawa, Shinsuke, Fujino, Hatsue, Ono, Atsushi, Nakahara, Takashi, Murakami, Eisuke, Miki, Daiki, Tsuge, Masataka, Teraoka, Yuji, Kouno, Hirotaka, Takaki, Shintaro, Mori, Nami, Tsuji, Keiji, Oka, Shiro
Publicado 2023

Effectiveness of Repeated Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma—Consideration of the Locations of Target Lesions

por Yano, Shigeki, Kimura, Tomoki, Kawaoka, Tomokazu, Kinami, Takahiro, Yamasaki, Shintaro, Johira, Yusuke, Kosaka, Masanari, Amioka, Kei, Naruto, Kensuke, Ando, Yuwa, Yamaoka, Kenji, Fujii, Yasutoshi, Uchikawa, Shinsuke, Fujino, Hatsue, Ono, Atsushi, Nakahara, Takashi, Murakami, Eisuke, Okamoto, Wataru, Yamauchi, Masami, Imamura, Michio, Hirokawa, Junichi, Nagata, Yasushi, Aikata, Hiroshi, Oka, Shiro
Publicado 2023

Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort study

por Johira, Yusuke, Nakahara, Takashi, Kinami, Takahiro, Yamasaki, Shintaro, Kosaka, Masanari, Shirane, Yuki, Miura, Ryoichi, Murakami, Serami, Yano, Shigeki, Amioka, Kei, Naruto, Kensuke, Ando, Yuwa, Kosaka, Yumi, Kodama, Kenichiro, Uchikawa, Shinsuke, Fujino, Hatsue, Ono, Atsushi, Murakami, Eisuke, Okamoto, Wataru, Yamauchi, Masami, Kawaoka, Tomokazu, Hayes, C. Nelson, Tsuge, Masataka, Imamura, Michio, Aikata, Hiroshi, Oka, Shiro
Publicado 2023

The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment

por Yamaoka, Kenji, Kodama, Kenichiro, Kawaoka, Tomokazu, Kosaka, Masanari, Johira, Yusuke, Shirane, Yuki, Miura, Ryoichi, Yano, Shigeki, Murakami, Serami, Amioka, Kei, Naruto, Kensuke, Ando, Yuwa, Kosaka, Yumi, Uchikawa, Shinsuke, Uchida, Takuro, Fujino, Hatsue, Nakahara, Takashi, Murakami, Eisuke, Okamoto, Wataru, Yamauchi, Masami, Miki, Daiki, Imamura, Michio, Takahashi, Shoichi, Nagao, Akiko, Chayama, Kazuaki, Aikata, Hiroshi
Publicado 2022

Hepatic venous pressure gradient after balloon-occluded retrograde transvenous obliteration and liver stiffness measurement predict the prognosis of patients with gastric varices

por Shirane, Yuki, Murakami, Eisuke, Imamura, Michio, Kosaka, Masanari, Johira, Yusuke, Miura, Ryoichi, Murakami, Serami, Yano, Shigeki, Amioka, Kei, Naruto, Kensuke, Ando, Yuwa, Uchikawa, Shinsuke, Teraoka, Yuji, Uchida, Takuro, Fujino, Hatsue, Ono, Atsushi, Nakahara, Takashi, Kawaoka, Tomokazu, Miki, Daiki, Yamauchi, Masami, Okamoto, Wataru, Tsuge, Masataka, Chosa, Keigo, Awai, Kazuo, Aikata, Hiroshi, Oka, Shiro
Publicado 2022

Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab

por Yano, Shigeki, Kawaoka, Tomokazu, Johira, Yusuke, Miura, Ryoichi, Kosaka, Masanari, Shirane, Yuki, Murakami, Serami, Amioka, Kei, Naruto, Kensuke, Ando, Yuwa, Kosaka, Yumi, Yamaoka, Kenji, Kodama, Kenichiro, Uchikawa, Shinsuke, Fujino, Hatsue, Ohno, Atsushi, Nakahara, Takashi, Murakami, Eisuke, Okamoto, Wataru, Yamauchi, Masami, Imamura, Michio, Mori, Keiichi, Arihiro, Kouji, Kuroda, Shintaro, Kobayashi, Tsuyoshi, Ohdan, Hideki, Aikata, Hiroshi
Publicado 2021

Analysis of Lenvatinib’s Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma

por Amioka, Kei, Kawaoka, Tomokazu, Kinami, Takahiro, Yamasaki, Shintaro, Kosaka, Masanari, Johira, Yusuke, Yano, Shigeki, Naruto, Kensuke, Ando, Yuwa, Fujii, Yasutoshi, Uchikawa, Shinsuke, Ono, Atsushi, Yamauchi, Masami, Imamura, Michio, Kosaka, Yumi, Ohya, Kazuki, Mori, Nami, Takaki, Shintaro, Tsuji, Keiji, Masaki, Keiichi, Honda, Yoji, Kouno, Hirotaka, Kohno, Hioshi, Morio, Kei, Moriya, Takashi, Naeshiro, Noriaki, Nonaka, Michihiro, Aisaka, Yasuyuki, Azakami, Takahiro, Hiramatsu, Akira, Aikata, Hiroshi, Oka, Shiro
Publicado 2022

Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma

por Amioka, Kei, Kawaoka, Tomokazu, Kosaka, Masanari, Johira, Yusuke, Shirane, Yuki, Miura, Ryoichi, Murakami, Serami, Yano, Shigeki, Naruto, Kensuke, Ando, Yuwa, Kosaka, Yumi, Fujii, Yasutoshi, Kodama, Kenichiro, Uchikawa, Shinsuke, Fujino, Hatsue, Ono, Atsushi, Nakahara, Takashi, Murakami, Eisuke, Okamoto, Wataru, Yamauchi, Masami, Imamura, Michio, Mori, Nami, Takaki, Shintaro, Tsuji, Keiji, Masaki, Keiichi, Honda, Yoji, Kouno, Hirotaka, Kohno, Hiroshi, Moriya, Takashi, Naeshiro, Noriaki, Nonaka, Michihiro, Hyogo, Hideyuki, Aisaka, Yasuyuki, Azakami, Takahiro, Hiramatsu, Akira, Aikata, Hiroshi
Publicado 2022